NEO6860, modality-selective TRPV1 antagonist: A randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain

Pierre Arsenault, Dan Chiche, William Brown, Jeffrey Miller, Roi Treister, Richard Leff, Philippe Walker, Nathaniel Katz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'NEO6860, modality-selective TRPV1 antagonist: A randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain'. Together they form a unique fingerprint.

Medicine & Life Sciences